XML 31 R22.htm IDEA: XBRL DOCUMENT
v3.25.3

Voluntary Bankruptcy Filing and Deconsolidation | 9 Months Ended
--- | ---
Sep. 30, 2025
Reorganizations [Abstract] |
Voluntary Bankruptcy Filing and Deconsolidation | Voluntary Bankruptcy Filing and Deconsolidation On September 22, 2025 (the "Petition Date"), the Company's wholly-owned subsidiary, ProPhase Diagnostics, Inc., and two indirectly wholly-owned subsidiaries, ProPhase Diagnostics NY, Inc. and ProPhase Diagnostics NJ, Inc. (collectively the "PDX") filed for a Chapter 11 reorganization in United States Bankruptcy Court for the District of New Jersey (the "Chapter 11 case"). On September 30, 2025, the Court granted the motion for joint administration. During the Chapter 11 Case, the Company is deemed to no longer control PDX as its activities are subject to review and oversight by the Bankruptcy Court. Therefore, PDX was deconsolidated from the Company’s condensed consolidated financial statements prospectively as of September 22, 2025. Deconsolidation of Bankrupt Subsidiaries In order to deconsolidate PDX, the carrying values of the assets and liabilities of PDX were removed from the Company’s condensed consolidated balance sheet as of September 22, 2025, in accordance with ASC 810, Consolidation. The net impact with removing the assets and liabilities held at PDX resulted in the recognition of the investment in unconsolidated affiliates of $43.7 million, and a payable to unconsolidated affiliates of $27.7 million on the Company’s condensed consolidated balance sheet as of September 30, 2025. Subsequent to the deconsolidation, the Company will account for the equity interest in PDX under the equity method of accounting as the Company is deemed to still have significant influence over PDX. All post-deconsolidation activities between the Company and PDX are reported as third-party transactions recorded within the Company's Unaudited Condensed Consolidated Statement of Operations. Since the Petition Date, there were no material transactions between the Company and PDX. Treatment of Intercompany Balances The Company had total payables to PDX of approximately $27.7 million. As a result of the deconsolidation of PDX, the Company recognized $27.7 million payable to the unconsolidated affiliates on the condensed consolidated balance sheet as of September 30, 2025.

X
- Definition The entire disclosure for the description and amounts of reorganization under Chapter 11 of the US Bankruptcy Code. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (c)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481404/852-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 852 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/852/tableOfContent + Details
Name: | us-gaap_ReorganizationUnderChapter11OfUSBankruptcyCodeDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ReorganizationsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration